Curis, Inc. (CRIS) financial statements (2020 and earlier)

Company profile

Business Address 4 MAGUIRE ROAD
LEXINGTON, MA 02421
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:28246045825058
Cash and cash equivalents2124382633810
Short-term investments712218494249
Other undisclosed cash, cash equivalents, and short-term investments(0)0(0)0   
Restricted cash and investments0    0 
Receivables3332221
Other undisclosed current assets2111101
Total current assets:33286448865260
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment0000000
Long-term investments and receivables     111
Long-term investments     111
Intangible assets, net (including goodwill)9999999
Goodwill9999999
Restricted cash and investments 000000
Other noncurrent assets0000000
Total noncurrent assets:109101091020
TOTAL ASSETS:42377458956381
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4689664
Accounts payable2356422
Accrued liabilities2333222
Employee-related liabilities     1 
Interest and dividends payable     0 
Debt0765563
Other undisclosed current liabilities (0)   (2) 
Total current liabilities:513141411107
Noncurrent Liabilities
Long-term debt and lease obligation 293615202328
Long-term debt, excluding current maturities 293615202328
Liabilities, other than long-term debt 000000
Other liabilities 000000
Other undisclosed noncurrent liabilities64     1
Total noncurrent liabilities:64293615202329
Total liabilities:68425028303335
Stockholders' equity
Stockholders' equity attributable to parent, including:(26)(4)2429653045
Common stock0021111
Treasury stock, value  (2)(2)(2)(2)(2)
Additional paid in capital982980976928903810807
Accumulated other comprehensive income (loss)0 (0)(0)0(0)(0)
Accumulated deficit(1,008)(985)(952)(899)(839)(780)(761)
Warrants and rights outstanding      1
Other undisclosed stockholders' equity attributable to parent      (1)
Total stockholders' equity:(26)(4)2429653045
TOTAL LIABILITIES AND EQUITY:42377458956381

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenue, net10881014
Gross profit:91010881015
Operating expenses(32)(40)(60)(66)(64)(26)(25)
Other undisclosed operating income     00
Operating loss:(22)(29)(50)(58)(56)(16)(9)
Nonoperating expense(7)(3)(4)(2)(3)(3)(3)
Investment income, nonoperating0    (1)0
Other nonoperating expense(6)(3)(4)(2)(3)  
Interest and debt expense(4)(4)(4)(3)(3)(4)(4)
Net loss:(34)(37)(57)(63)(62)(22)(16)
Other undisclosed net income attributable to parent4443344
Net loss available to common stockholders, diluted:(29)(33)(53)(60)(59)(19)(12)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(34)(37)(57)(63)(62)(22)(16)
Comprehensive loss:(34)(37)(57)(63)(62)(22)(16)
Other undisclosed comprehensive income, net of tax, attributable to parent4443344
Comprehensive loss, net of tax, attributable to parent:(29)(33)(53)(60)(59)(19)(12)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: